| (Values in U.S. Thousands) | Dec, 2012 | Dec, 2011 | Mar, 2018 | Dec, 2017 | Sep, 2017 |
| Sales | 145,100 | 212,690 | 0 | 0 | 0 |
| Sales Growth | -31.78% | unch | unch | unch | unch |
| Net Income | -59,710 | -67,450 | 0 | 0 | 0 |
| Net Income Growth | +11.48% | unch | unch | unch | unch |
American Oriental Bioengineering Inc (AOBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
AMERICAN ORIENTAL BIOENGINEERING INC. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products in China.
Fiscal Year End Date: 12/31